Dan Wetherill

Dan Wetherill is a partner at Beghou Consulting.

Articles

To Reduce Commercial Risk for Orphan Drugs, Transform Forecasting

To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.